More About Ginger
Ginger Liau is a partner on the Bio + Health team focused on biotech. She leads business development for the CFI ife sciences portfolio.
Prior to joining Andreessen Horowitz, Ginger worked at Alnylam Pharmaceuticals where she held a variety of positions across the business. She worked as an RNA chemist before moving into strategy and operations roles in business planning, program management, and investor relations.
Ginger graduated summa cum laude from Vanderbilt University where she majored in Chemistry and Math. She earned her MBA from Stanford Graduate School of Business.
